种族与民族差异对扩张型心肌病患者的影响:JACC焦点研讨会7/9
该文指出扩张型心肌病(DCM)的诊断与治疗存在显著的种族和民族差异,且根植于社会历史。黑人受试者DCM发病率更高,黑人患者生存率及其他结局更差,心脏移植转诊更少,有效治疗被低估和转诊不足。文章呼吁采取多方面策略,包括政策变革、保险、教育、住房以及解决医疗工作者的种族主义和偏见,以促进健康公平。
要点
- 黑人患者DCM发病率更高,生存率更差,心脏移植转诊更少。
- DCM在黑人患者中被低估且有效治疗转诊不足。
- 需多层面策略解决健康社会决定因素以消除差异。
核心结论
- DCM存在显著的种族和民族差异,黑人患者发病率更高且结局更差,需采取社会正义方法消除差异。
研究设计与样本
- 本文为JACC焦点研讨会,基于文献综述讨论DCM的种族和民族差异。
主要发现
- 黑人受试者DCM发病率更高;黑人DCM患者生存率和其他结局指标更差,心脏移植转诊更少。
- 黑人患者DCM被低估且有效治疗转诊不足,是社会和社会经济因素复杂相互作用的结果。
临床怎么用
- 管理健康社会决定因素需多层面策略,包括政策变革扩大公平护理可及性、提供保险、教育和住房、解决医疗工作者的种族主义和偏见。
- 迫切需要优先考虑医疗保健的社会正义方法和追求健康公平,以消除心血管疾病管理中的种族和其他差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Significant race- and ethnicity-based disparities among those diagnosed with dilated cardiomyopathy (DCM) exist and are deeply rooted in the history of many societies. The role of social determinants of racial disparities, including racism and bias, is often overlooked in cardiology. DCM incidence is higher in Black subjects; survival and other outcome measures are worse in Black patients with DCM, with fewer referrals for transplantation. DCM in Black patients is underrecognized and under-referred for effective therapies, a consequence of a complex interplay of social and socioeconomic factors. Strategies to manage social determinants of health must be multifaceted and consider changes in policy to expand access to equitable care; provision of insurance, education, and housing; and addressing racism and bias in health care workers. There is an urgent need to prioritize a social justice approach to health care and the pursuit of health equity to eliminate race and other disparities in the management of cardiovascular disease.
引用
- Ntusi NAB, Sliwa K. Impact of Racial and Ethnic Disparities on Patients With Dilated Cardiomyopathy: JACC Focus Seminar 7/9. J Am Coll Cardiol. 2021. PMID: 34887144. doi:10.1016/j.jacc.2021.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。